EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications

Wesley T Kerr iD, Neo Kok iD, Katherine N McFarlane iD, Advith S Reddy iD, Lavanya Biju, Jacqueline A French iD, Daniel M Goldenholz iD

Epilepsia · 2025

DOI: 10.1002/epi.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Wesley T Kerr und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: American Academy of Neurology, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Antiseizure medications are approved based on clinical trials that demonstrate their efficacy as measured by reductions in seizure frequency (SF). When designing these trials, trialists must select inclusion criteria where SF can be reliably measured to maintain statistical power. Statistical power is based on the magnitude and uncertainty of the difference between active treatment and placebo. To inform choices about how minimum, maximum, and individual participant SF impacts the statistical power of trials, we evaluated how the uncertainty in SF was associated with average SF within multiple clinical trials.

Methods

Using data from 11 double‐blind placebo‐controlled trials of antiseizure medications for either focal or generalized onset epilepsy, we used log–log multivariable regression to associate the SD of SF in maintenance with the average SF in baseline and maintenance. We also evaluated whether capturing more seizures in people with high average SF offset the increased uncertainty in SF and asked whether these associations persisted when time to event designs were used.

Results

The uncertainty (SD) of maintenance SF was proportional to baseline average SF (daily diaries: slope of log–log association = .575, 95% confidence interval [CI] = .556–.593; fortnightly diaries: .657, 95% CI = .0642–.0671). Increased uncertainty for high SF was offset by counting more seizures. These relationships were maintained with a time to event design. Significance This study validates the foundational L‐relationship between average and SD of SF in which the uncertainty of seizure counts increased proportional to the number of seizures counted. When used for efficacy outcomes of trials, the statistical benefit of counting more seizures in participants with high SF was much greater than the increased challenge from higher uncertainty seizure counts. These results provide quantitative insights for SF‐based inclusion criteria and statistical power calculations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsSeizuresHumansUncertaintyDouble-Blind MethodMaleFemaleAdultMiddle AgedTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

L‐relationshipantiepileptic drugsclinical trialsepilepsytime to event

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Comprehensive Epilepsy Center, New York University, New York, New York, USA.
  • Division of Epilepsy, Beth Israel Medical Center, Boston, Massachusetts, USA.
  • Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Wesley T Kerr, Neo Kok, Katherine N McFarlane, Advith S Reddy, Jacqueline A French, Daniel M Goldenholz

Förderung

  • American Academy of Neurology
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Kerr, W. T., Kok, N., McFarlane, K. N., Reddy, A. S., Biju, L., French, J. A., & Goldenholz, D. M. (2025). L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications. Epilepsia. https://doi.org/10.1002/epi.70080

Vancouver

Kerr WT, Kok N, McFarlane KN, Reddy AS, Biju L, French JA, et al. L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications. Epilepsia. 2025. doi:10.1002/epi.70080

BibTeX
@article{Kerr2025,
  author = {Kerr, Wesley T and Kok, Neo and McFarlane, Katherine N and Reddy, Advith S and Biju, Lavanya and French, Jacqueline A and Goldenholz, Daniel M},
  title = {L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1002/epi.70080}
}
Kostenlos starten →